• 1. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Excitation dependent recombination studies on SnO2/TiO2 electrospun nanofibers?
  Veluru Jagadeesh babu,Sesha Vempati RSC Adv., 2015,5, 66367-66375
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes

Professional Introduction to N,N-Dimethyl-4-nitrobenzamide (CAS No. 7291-01-2)

N,N-Dimethyl-4-nitrobenzamide, with the chemical formula C₈H₉NO₃, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This compound is characterized by its N,N-Dimethyl-4-nitrobenzamide structure, which includes a nitro group at the 4-position of the benzamide backbone. The presence of both methyl groups and a nitro group imparts unique electronic and steric properties, making it a valuable intermediate in the synthesis of various biologically active molecules.

The CAS No. 7291-01-2 identifier is a crucial reference point for researchers and chemists, ensuring precise identification and differentiation from other structurally similar compounds. This compound has garnered attention in recent years due to its potential applications in medicinal chemistry and drug discovery. Its molecular framework suggests utility in the development of novel therapeutic agents, particularly those targeting neurological and inflammatory disorders.

In recent studies, N,N-Dimethyl-4-nitrobenzamide has been explored as a precursor in the synthesis of more complex heterocyclic compounds. The nitro group can be further functionalized through reduction or coupling reactions, leading to the formation of amine derivatives or azo compounds. These transformations have opened up new avenues for designing molecules with enhanced pharmacological properties.

One of the most compelling aspects of N,N-Dimethyl-4-nitrobenzamide is its role in the development of enzyme inhibitors. The benzamide moiety is a common pharmacophore in drug design, known for its ability to interact with specific enzymatic targets. By incorporating a nitro group at the 4-position, researchers can modulate the electronic properties of the molecule, potentially improving binding affinity and selectivity. This has led to several investigations into its derivatives as inhibitors of enzymes involved in cancer metabolism and inflammation.

The synthesis of N,N-Dimethyl-4-nitrobenzamide typically involves the nitration of 4-formylbenzoic acid followed by amidation with dimethylamine. This multi-step process highlights the compound's importance as a synthetic intermediate. Recent advancements in catalytic methods have improved the efficiency and yield of this synthesis, making it more accessible for large-scale production.

From a computational chemistry perspective, N,N-Dimethyl-4-nitrobenzamide has been studied to understand its molecular interactions and binding modes. Molecular docking simulations have shown that this compound can effectively bind to various protein targets, suggesting its potential as a lead compound in drug development. The nitro group's ability to engage in hydrogen bonding and hydrophobic interactions further enhances its binding capabilities.

The pharmacological profile of N,N-Dimethyl-4-nitrobenzamide has been evaluated in several preclinical studies. These studies have revealed promising results in terms of anti-inflammatory and analgesic activities. The compound's ability to modulate inflammatory pathways makes it a candidate for treating chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

In addition to its therapeutic potential, N,N-Dimethyl-4-nitrobenzamide has found applications in materials science. Its unique electronic properties make it suitable for use in organic electronics and photovoltaic devices. Researchers are exploring its role as an electron acceptor in dye-sensitized solar cells (DSSCs), where it could improve energy conversion efficiency.

The environmental impact of synthesizing and using N,N-Dimethyl-4-nitrobenzamide is also an area of growing interest. Green chemistry principles have been applied to develop more sustainable synthetic routes, reducing waste and minimizing hazardous byproducts. These efforts align with global initiatives to promote environmentally friendly chemical processes.

Future research directions for N,N-Dimethyl-4-nitrobenzamide include exploring its role in drug repurposing efforts. By re-evaluating existing drugs or drug candidates, scientists may uncover new therapeutic applications for this compound. Additionally, investigating its interactions with other molecules could lead to the discovery of new mechanisms underlying disease pathogenesis.

In conclusion, N,N-Dimethyl-4-nitrobenzamide (CAS No. 7291-01-2) is a versatile compound with significant implications in pharmaceutical chemistry, bioorganic synthesis, and materials science. Its unique structural features make it a valuable tool for developing novel therapeutic agents and advanced materials. As research continues to uncover new applications for this compound, its importance in scientific innovation is likely to grow.

• 2433-21-8(N,N-Diethyl-3-nitrobenzamide)
• 92700-26-0(N,N-Di-n-butyl-4-nitrobenzamide)
• 2585-23-1(N-Methyl-4-nitrobenzamide)
• 3400-26-8(N-Methyl-3-nitrobenzamide)
• 79868-22-7(4-nitro-N,N-dipropylbenzamide)
• 2585-27-5(Benzamide,4-nitro-N,N-bis(phenylmethyl)-)
• 5323-47-7(N,N-Diethyl-4-nitrobenzamide)
• 89399-23-5(Benzamide, N-methyl-4-nitro-N-(phenylmethyl)-)
• 79606-48-7(Benzamide,N,N-bis(1-methylethyl)-4-nitro-)
• 7291-02-3(N,N-Dimethyl-3-nitrobenzamide)